Jorge Cortes, MD, Augusta University, Augusta, GA, briefly discusses exciting updates in the field of chronic myeloid leukemia (CML), highlighting the discovery of additional mutations in other cancer-related genes and how these play a role in the heterogeneity of this disease. Dr Cortes also shares insights into exciting new agents being explored, including olverembatinib and vodobatinib. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.